Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals

Journal of Experimental Medicine

Volumn 210, Issue 13, 2013, Pages 2823-2832

  Heizmann, Beate ^a   Kastner, Philippe ^a   Chan, Susan ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 7; PRE B CELL RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EBF1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE PHASE; CELL MATURATION; CELL METABOLISM; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC REGULATION; KNOCKOUT MOUSE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VDJ RECOMBINATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; DOWN-REGULATION; FLOW CYTOMETRY; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; INTERLEUKIN-7; LEUKEMIA; MICE; MICE, KNOCKOUT; MUTATION; PHENOTYPE; RECOMBINATION, GENETIC; RETROVIRIDAE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; VDJ RECOMBINASES;

EID: 84890834574     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131735     Document Type: Article

References (34)

1. Alkhatib, A., M. Werner, E. Hug, S. Herzog, C. Eschbach, H. Faraidun, F. Köhler, T. Wossning, and H. Jumaa. 2012. FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination. J. Exp. Med. 209:395-406. http://dx.doi.org/10.1084/jem.20110216
2. Amin, R.H., and M.S. Schlissel. 2008. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9:613-622. http://dx.doi.org/10.1038/ni.1612
3. Baba, M., J.R. Keller, H.W. Sun, W. Resch, S. Kuchen, H.C. Suh, H. Hasumi, Y. Hasumi, K.R. Kieffer-Kwon, C.G. Gonzalez, et al. 2012. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development. Blood. 120:1254-1261. http://dx.doi.org/10.1182/blood-2012-02-410407
4. Corfe, S.A., and C.J. Paige. 2012. The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation. Semin. Immunol. 24:198-208. http://dx.doi.org/10.1016/j.smim.2012.02.001
5. Dupuis, A., M.P. Gaub, M. Legrain, B. Drenou, L. Mauvieux, P. Lutz, R. Herbrecht, S. Chan, and P. Kastner. 2013. Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia. 27:503-507. http://dx.doi.org/10.1038/leu.2012.204
6. Eilers, M., and R.N. Eisenman. 2008. Myc's broad reach. Genes Dev. 22:2755-2766. http://dx.doi.org/10.1101/gad.1712408
7. Engelmann, A., D. Speidel, G.W. Bornkamm, W. Deppert, and C. Stocking. 2008. Gadd45 beta is a pro-survival factor associated with stress-resistant tumors. Oncogene. 27:1429-1438. http://dx.doi.org/10.1038/sj.onc.1210772
8. Ferreirós-Vidal, I., T. Carroll, B. Taylor, A. Terry, Z. Liang, L. Bruno, G. Dharmalingam, S. Khadayate, B.S. Cobb, S.T. Smale, et al. 2013. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation. Blood. 121:1769-1782. http://dx.doi.org/10.1182/blood-2012-08-450114
9. Fuxa, M., J. Skok, A. Souabni, G. Salvagiotto, E. Roldan, and M. Busslinger. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18:411-422. http://dx.doi.org/10.1101/gad.291504
10. Gachet, S., E. Genescà, D. Passaro, M. Irigoyen, H. Alcalde, C. Clémenson, S. Poglio, F. Pflumio, A. Janin, C. Lasgi, et al. 2013. Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia. Leukemia. http://dx.doi.org/10.1038/leu.2013.156
11. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334: 676-682. http://dx.doi.org/10.1038/334676a0
12. Harvey, R.C., C.G. Mullighan, I.M. Chen, W. Wharton, F.M. Mikhail, A.J. Carroll, H. Kang, W. Liu, K.K. Dobbin, M.A. Smith, et al. 2010. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 115:5312-5321. http://dx.doi.org/10.1182/blood-2009-09-245944
13. Herzog, S., E. Hug, S. Meixlsperger, J.H. Paik, R.A. DePinho, M. Reth, and H. Jumaa. 2008. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat. Immunol. 9:623-631. http://dx.doi.org/10.1038/ni.1616
14. Herzog, S., M. Reth, and H. Jumaa. 2009. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat. Rev. Immunol. 9:195-205. http://dx.doi.org/10.1038/nri2491
15. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P.J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA. 103:13789-13794. http://dx.doi.org/10.1073/pnas.0605944103
16. Kastner, P., A. Dupuis, M.P. Gaub, R. Herbrecht, P. Lutz, and S. Chan. 2013. Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia. Am. J. Blood Res. 3:1-13.
17. Kirstetter, P., M. Thomas, A. Dierich, P. Kastner, and S. Chan. 2002. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32:720-730. http://dx.doi.org/10.1002/1521-4141(200203)32:3<720:: AID-IMMU720>3.0.CO;2-P
18. Lu, R., K.L. Medina, D.W. Lancki, and H. Singh. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17:1703-1708. http://dx.doi.org/10.1101/gad.1104803
19. Ma, S., S. Pathak, L. Trinh, and R. Lu. 2008. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood. 111:1396-1403. http://dx.doi.org/10.1182/blood-2007-08-110106
20. Ma, S., S. Pathak, M. Mandal, L. Trinh, M.R. Clark, and R. Lu. 2010. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol. Cell. Biol. 30:4149-4158. http://dx.doi.org/10.1128/MCB.00224-10
21. Malin, S., S. McManus, C. Cobaleda, M. Novatchkova, A. Delogu, P. Bouillet, A. Strasser, and M. Busslinger. 2010. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat. Immunol. 11:171-179. http://dx.doi.org/10.1038/ni.1827
22. Mandal, M., S.E. Powers, M. Maienschein-Cline, E.T. Bartom, K.M. Hamel, B.L. Kee, A.R. Dinner, and M.R. Clark. 2011. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat. Immunol. 12:1212-1220. http://dx.doi.org/10.1038/ni.2136
23. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, et al. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1506-1510. http://dx.doi.org/10.1126/science.7878471
24. Mullighan, C.G., C.B. Miller, I. Radtke, L.A. Phillips, J. Dalton, J. Ma, D. White, T.P. Hughes, M.M. Le Beau, C.H. Pui, et al. 2008. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 453:110-114. http://dx.doi.org/10.1038/nature06866
25. Park, H., K. Staehling, M. Tsang, M.W. Appleby, M.E. Brunkow, D. Margineantu, D.M. Hockenbery, T. Habib, H.D. Liggitt, G. Carlson, and B.M. Iritani. 2012. Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity. 36:769-781. http://dx.doi.org/10.1016/j.immuni.2012.02.019
26. Pieper, K., B. Grimbacher, and H. Eibel. 2013. B-cell biology and development. J. Allergy Clin. Immunol. 131:959-971. http://dx.doi.org/10.1016/j.jaci.2013.01.046
27. Reynaud, D., I.A. Demarco, K.L. Reddy, H. Schjerven, E. Bertolino, Z. Chen, S.T. Smale, S. Winandy, and H. Singh. 2008. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9:927-936. http://dx.doi.org/10.1038/ni.1626
28. Sabbattini, P., M. Lundgren, A. Georgiou, C. Chow, G. Warnes, and N. Dillon. 2001. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20:2812-2822. http://dx.doi.org/10.1093/emboj/20.11.2812
29. Schjerven, H., J. McLaughlin, T.L. Arenzana, S. Frietze, D. Cheng, S.E. Wadsworth, G.W. Lawson, S.J. Bensinger, P.J. Farnham, O.N. Witte, and S.T. Smale. 2013. Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros. Nat. Immunol. 14: 1073-1083. http://dx.doi.org/10.1038/ni.2707
30. Thompson, E.C., B.S. Cobb, P. Sabbattini, S. Meixlsperger, V. Parelho, D. Liberg, B. Taylor, N. Dillon, K. Georgopoulos, H. Jumaa, et al. 2007. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity. 26:335-344. http://dx.doi.org/10.1016/j.immuni.2007.02.010
31. Trageser, D., I. Iacobucci, R. Nahar, C. Duy, G. von Levetzow, L. Klemm, E. Park, W. Schuh, T. Gruber, S. Herzog, et al. 2009. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J. Exp. Med. 206:1739-1753. http://dx.doi.org/10.1084/jem.20090004
32. Uckun, F.M., H. Ma, J. Zhang, Z. Ozer, S. Dovat, C. Mao, R. Ishkhanian, P. Goodman, and S. Qazi. 2012. Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proc. Natl. Acad. Sci. USA. 109:18072-18077. http://dx.doi.org/10.1073/pnas.1209828109
33. Wang, J.H., A. Nichogiannopoulou, L. Wu, L. Sun, A.H. Sharpe, M. Bigby, and K. Georgopoulos. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 5:537-549. http://dx.doi.org/10.1016/S1074-7613(00)80269-1
34. Winkler, T.H., F. Melchers, and A.G. Rolink. 1995. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood. 85:2045-2051